Registry for closing heart opening in premature babies
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial creates a registry to gather information on premature babies who have a PDA (an open blood vessel in the heart) and are getting it closed with a catheter-based device. It helps doctors learn more about how safe and effective this treatment is for these tiny babies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must have an opening in the heart called a patent ductus arteriosus (PDA), which normally closes after birth.
- Your doctor must recommend closing the PDA with a small tube (catheter) procedure.
- At the time of the procedure, your baby must weigh between 700 grams and 2 kilograms (about 1.5 to 4.4 pounds).
- Your baby must be at least 3 days old when the procedure is done.
- Your baby cannot have certain heart problems, like a narrowed aorta or a lung artery, or an untreated infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares an early procedure to close a heart vessel called the ductus arteriosus versus careful observation alone in very low-birth-weight preterm infants. It aims to see whether closing the vessel early can improve outcomes and be done safely.
This trial tests a procedure that closes a small heart tube (called the ductus arteriosus) that stays open after birth. The goal is to see if closing it helps the heart work better in teens and adults.
This study looks at how well a procedure called transcatheter closure works for children with Patent Ductus Arteriosus (PDA), a small extra blood vessel in the heart that should close after birth. The procedure uses a thin tube (catheter) to close the vessel without open surgery, and researchers want to see how children do over a 3-year period.
This study tests a personalized approach to treating a common heart condition in very early preterm babies, where a blood vessel (the ductus arteriosus) stays open. It aims to find the best time and way to close this vessel using medication, based on the baby's specific biomarkers.
This study checks how well and how safely the Occlutech PDA Occluder works over time to close a patent ductus arteriosus (PDA). You may be considered if your PDA can be treated with this non-surgical device and you can return for follow-up visits.
This study looks at how certain signs seen on ultrasound can help doctors manage a common heart condition in premature babies called patent ductus arteriosus (PDA). Your baby's heart ultrasound will be checked for these signs, which may guide treatment decisions.
Hear when a new Ductus Arteriosus, Patent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.